Biochemistry professor to discuss controversies in dietary strategies in diabetes treatment

Site is convention of European Association for the Study of Diabetes

Richard Feinman, PhD, professor of biochemistry and of family medicine at SUNY Downstate Medical Center in Brooklyn, New York, will speak at the annual conference of the European Association for the Study of Diabetes (EASD) on October 2, 2009. EASD is holding its annual conference September 28 - October 2 in Vienna, Austria.

Dr. Feinman will be one of four speakers covering the topic, Controversies in Dietary Strategies in the Treatment of Diabetes.

According to Dr. Feinman, it has been scientifically documented that carbohydrate consumption raises blood glucose and there is no disagreement that diabetes is a disease of carbohydrate intolerance. "There really is no controversy about the science," Dr. Feinman explains. "It's as simple as this: An increase in dietary carbohydrate will raise HbA1c, which in turn will raise the risk of microvascular complications, and this is science we all agree on."

"That being said," he adds, "the controversy may indeed be whether or not we are getting good advice from our healthcare professionals, but that is out of my area - I will be at the conference in Vienna to explain the science."

Dr. Feinman's presentation will take place at the Messe Wien in van Swieten Hall on October 2, 2009.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Protein in the blood could predict type 2 diabetes many years before diagnosis